Applying Pharmacogenetic Algorithms to Individualize Dosing of Warfarin
Clinical trial NCT00927862 · COMPLETED
Trial details
- NCT number
- NCT00927862
- Sponsor
- Intermountain Health Care, Inc.
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-08-01
- Primary completion
- 2010-12-01
- Enrollment
- 2415
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.